Review
doi: 10.1177/0004563216652175.
Epub 2016 Sep 28.
Multiple sclerosis: assay of free immunoglobulin light chains
Affiliations
- PMID: 27170023
- DOI: 10.1177/0004563216652175
Item in Clipboard
Review
Multiple sclerosis: assay of free immunoglobulin light chains
Ann Clin Biochem.
2017 Jan.
Abstract
Over the past five years, a number of papers have appeared describing the assay of free immunoglobulin light chains in cerebrospinal fluid to assist in the diagnosis of multiple sclerosis. The assay of kappa free immunoglobulin chains is being advocated as a technically simpler and cheaper quantitative alternative to the qualitative detection of oligoclonal bands. This article reviews the analytical and clinical characteristics of these immunoglobulin free light chain assays and places them in their historical context and possible future developments.
Keywords: Analytical systems; clinical studies; immunoassay; laboratory methods; neurological disorders.
Similar articles
-
Multiple sclerosis: use of light-chain typing to assist diagnosis.Ann Clin Biochem. 2001 May;38(Pt 3):235-41. doi: 10.1258/0004563011900669. Ann Clin Biochem. 2001. PMID: 11392498
-
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.Eur J Neurol. 2020 Mar;27(3):461-467. doi: 10.1111/ene.14121. Epub 2019 Dec 2. Eur J Neurol. 2020. PMID: 31710409
-
Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study.J Neuroimmunol. 1991 Jul;33(1):63-72. doi: 10.1016/0165-5728(91)90035-6. J Neuroimmunol. 1991. PMID: 1829093
-
[Oligoclonal antibodies in the diagnosis of multiple sclerosis and other diseases of the nervous system].Neurol Neurochir Pol. 1991 May-Jun;25(3):363-70. Neurol Neurochir Pol. 1991. PMID: 1961384 Review. Polish.
-
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.Wien Med Wochenschr. 2022 Nov;172(15-16):337-345. doi: 10.1007/s10354-022-00912-7. Epub 2022 Feb 8. Wien Med Wochenschr. 2022. PMID: 35133530 Free PMC article. Review.
Cited by
-
Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment.Diagnostics (Basel). 2022 Mar 16;12(3):720. doi: 10.3390/diagnostics12030720. Diagnostics (Basel). 2022. PMID: 35328273 Free PMC article.
-
Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1044-1049. doi: 10.1136/jnnp-2018-317947. Epub 2018 May 9. J Neurol Neurosurg Psychiatry. 2018. PMID: 29743290 Free PMC article.
-
Kappa free light chains index in multiple sclerosis very long-term prognosis.Front Immunol. 2023 Oct 11;14:1223514. doi: 10.3389/fimmu.2023.1223514. eCollection 2023. Front Immunol. 2023. PMID: 37885887 Free PMC article.
-
The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis.Medicina (Kaunas). 2022 Oct 24;58(11):1512. doi: 10.3390/medicina58111512. Medicina (Kaunas). 2022. PMID: 36363469 Free PMC article.
-
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis.Neurol Neuroimmunol Neuroinflamm. 2020 Jul 14;7(5):e831. doi: 10.1212/NXI.0000000000000831. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32665296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
